Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRAMETINIB for K-ras gene mutation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 15 adverse event reports in the FDA FAERS database where TRAMETINIB was used for K-ras gene mutation.

Most Reported Side Effects for TRAMETINIB

Side Effect Reports % Deaths Hosp.
Pyrexia 1,096 18.8% 113 640
Malignant neoplasm progression 807 13.8% 320 205
Product use in unapproved indication 349 6.0% 33 36
Diarrhoea 325 5.6% 42 183
Nausea 301 5.2% 67 172
Rash 290 5.0% 25 96
Vomiting 289 5.0% 59 187
Fatigue 269 4.6% 39 127
Death 240 4.1% 240 40
Chills 227 3.9% 29 128
Asthenia 193 3.3% 42 92
Drug ineffective 192 3.3% 77 53
Anaemia 184 3.2% 32 124
Off label use 176 3.0% 37 38
Metastatic malignant melanoma 173 3.0% 119 75

Other Indications for TRAMETINIB

Metastatic malignant melanoma (1,604) Malignant melanoma (1,448) Product used for unknown indication (505) Non-small cell lung cancer (191) Colorectal cancer (158) Glioma (139) Braf gene mutation (94) Neoplasm (84) Neoplasm malignant (81) Braf v600e mutation positive (80)

Other Drugs Used for K-ras gene mutation

SOTORASIB (752) AMG-510 (173) IRINOTECAN (40) PANITUMUMAB (36) CETUXIMAB (29) PEMBROLIZUMAB (28) BEVACIZUMAB (19) DALOTUZUMAB (18) CARBOPLATIN (17) FLUOROURACIL (17)

Related Pages

TRAMETINIB Full Profile All K-ras gene mutation Drugs TRAMETINIB Demographics TRAMETINIB Timeline